Cardiac Magnetic Resonance and Echocardiography Study With Acoramidis

Clinical trial NCT07695701 · RECRUITING

Trial details

NCT number: NCT07695701
Sponsor: Eidos Therapeutics, a BridgeBio company
Status: RECRUITING
Phase: Phase 4
Study type: INTERVENTIONAL

Transthyretin Amyloidosis Cardiomyopathy (ATTR-CM)Amyloidosis Amyloid Cardiomyopathy Transthyretin Amyloidosis

Start date: 2026-07-01
Primary completion: 2030-08-01
Enrollment: 150

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.